To define a molecular signature independent of PSA, we excluded this criterion and categorized tumor specimens into low-, intermediate-, and high-risk groups uniquely on the basis of Gleason and TNM features, below referred to as naïve indexing (Fig S6A and B). This evidence concerns the gene PROS1 and neoplasm.